Genomes and Genes

W A Schulz

Summary

Affiliation: Heinrich Heine University
Country: Germany

Publications

  1. Schulz W, Ingenwerth M, Djuidje C, Hader C, Rahnenf├╝hrer J, Engers R. Changes in cortical cytoskeletal and extracellular matrix gene expression in prostate cancer are related to oncogenic ERG deregulation. BMC Cancer. 2010;10:505 pubmed publisher
    ..We hypothesize that these alterations may contribute to the increased invasivity conferred to prostate cancer cells by ERG deregulation. ..
  2. Isono M, Hoffmann M, Pinkerneil M, Sato A, Michaelis M, Cinatl J, et al. Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine. J Exp Clin Cancer Res. 2017;36:1 pubmed publisher
    ..AZD7762 enhanced sensitivity of urothelial carcinoma cells to gemcitabine by inhibiting DNA repair and disturbing checkpoints. Combining gemcitabine with CHK1 inhibition holds promise for urothelial cancer therapy. ..

Detail Information

Publications2

  1. Schulz W, Ingenwerth M, Djuidje C, Hader C, Rahnenf├╝hrer J, Engers R. Changes in cortical cytoskeletal and extracellular matrix gene expression in prostate cancer are related to oncogenic ERG deregulation. BMC Cancer. 2010;10:505 pubmed publisher
    ..We hypothesize that these alterations may contribute to the increased invasivity conferred to prostate cancer cells by ERG deregulation. ..
  2. Isono M, Hoffmann M, Pinkerneil M, Sato A, Michaelis M, Cinatl J, et al. Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine. J Exp Clin Cancer Res. 2017;36:1 pubmed publisher
    ..AZD7762 enhanced sensitivity of urothelial carcinoma cells to gemcitabine by inhibiting DNA repair and disturbing checkpoints. Combining gemcitabine with CHK1 inhibition holds promise for urothelial cancer therapy. ..